NCT06635421Not yet recruiting
The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV
Source: ClinicalTrials.gov · Last updated 10 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of The EXPAND study is to develop and pilot a pharmacist led model of medication delivery. Following a co-design phase, patients may receive injections at satellite pharmacies by a licensed pharmacist. The acceptability, appropriateness, and feasibility of this approach and standard in clinic administration by a nurse will be assessed.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 164 (estimated)
- First submitted
- 3 Oct 2024
- Start date
- 1 Nov 2024
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- MetroHealth Medical Center
- Diseases
- HIV
- NCT number
- NCT06635421
What you commit to
- Study type: Observational
- Planned participants: 164
- From 1 Nov 2024 to the primary completion date, 31 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Patient Participant Inclusion Criteria:
- 18 years of age and older
- diagnosed with HIV by approved HIV screen and confirmation test
- currently on CAB+RPV LA every 4 or 8 weeks
- has received at least two doses of CAB+PRV LA
- last HIV-1 RNA \<50 copies/ml
- no known or suspected resistance to either cabotegravir or rilpivirine
- no plans to change medication in the next 48 weeks
- no plans to move out of state
- has plans to avoid pregnancy if of reproductive potential
- Patient Participant Exclusion Criteria:
- individuals who are unable or unwilling to adhere to the study protocol
- unable to speak/comprehend English
- insurance coverage for medication through medical benefit
- Staff Participant Inclusion/Exclusion Criteria:
- -all available staff involved in the CAB+RPV LA workflow will be approached for inclusion
Age in the registry: 18 years to - · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.